ISB-1908

N/A

Report date: 2026/03/19 16:57:32

Base Information

Drug NameISB-1908

Drug Alias Nameanti-CD3/anti-CD38 bispecific antibody (BEAT) (Ichnos Sciences)anti-CD3/anti-CD38 bispecific T-cell engager (BEAT) (Ichnos Sciences)ISB-1908

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionLymphocyte differentiation antigen CD38 modulatorsT cell surface glycoprotein CD3 modulators

TargetsLymphocyte differentiation antigen CD38T cell surface glycoprotein CD3

Therapy Area/IndicationsMultiple MyelomaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIchnos Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIchnos Sciences Inc

Active IndicationsN/A

Inactive IndicationsMultiple MyelomaNeoplasms

Other Information

ATC CodeN/A